Capsaicin-induced biphasic oxygen uptake in rat muscle: Antagonism by capsazepine and ruthenium red provides further evidence for peripheral vanilloid receptor subtypes (VN1/VN2)

Life Sciences

Volumn 59, Issue 2, 1996, Pages 105-117

  Griffiths, Cory D ^a   Eldershaw, Tristram P D ^a   Geraghty, Dominic P ^a   Hall, Jennifer L ^a   Colquhoun, Eric Q ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Capsaicin; Capsazepine; Oxygen consumption; Receptor subtypes; Ruthenium red; Vasoconstriction

Indexed keywords

CAPSAICIN; CAPSAZEPINE; RECEPTOR SUBTYPE; RUTHENIUM RED; TETRODOTOXIN; VANILLOID RECEPTOR;

ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; LIMB PERFUSION; MUSCLE METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; RAT; TARGET ORGAN;

ANIMALS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; MALE; MUSCLES; OXYGEN; RATS; RATS, WISTAR; RECEPTORS, DRUG; RUTHENIUM RED;

ANIMALIA;

EID: 0029892544     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00267-6     Document Type: Article

References (37)

1. E.Q. COLQUHOUN, T.P.D. ELDERSHAW, K.L. BENNETT, J.L. HALL, K.A. DORA, & M.G. CLARK, Life Sci. 57 91-102 (1995).
2. P. HOLZER, Pharmacol. Rev. 42 143-201 (1991).
3. S.J. BEVAN & R.J. DOCHERTY, Capsaicin in the study of pain. Wood, J.N. (Ed.), 27-44, Academic Press Ltd, London (1993).
4. J.N. WOOD, J. WINTER, I.F. JAMES, H.P. RANG, J YEATS, & S. BEVAN, J. Neurosci. 8 3208-3220 (1988).
5. S. BEVAN & J. SZOLSCANYI, Trends Pharmacol. Sci. 11 330-333 (1991).
6. I.F. JAMES, N. NINKINA, & J.N. WOOD,. Capsaicin in the study of pain,. J.N. Wood, (Ed.), 27-44, Academic Press Ltd, London (1993).
7. L. URBAN & A. DRAY, Neurosci. Lett. 134 9-11 (1991).
8. A.H. DICKENSON & A. DRAY, Br. J. Pharmacol. 104 1045-1049 (1991).
9. S.J. BEVAN, S. HOTHI, G. HUGHES, IF. JAMES, H.P. RANG, K. SHAH, C.S.J. WALPOLE, & J.C. YEATS, Br. J. Pharmacol. 107 544-552 (1992).
10. C.A. MAGGI, S. BEVAN, C.S.J. WALPOLE, H.P. RANG, & S. GIULIANI, Br. J. Pharmacol. 108 801-805 (1993).
11. A. SZALLASI & P.M. BLUMBERG, Brain Res. 524 106-111 (1990a).
12. A. SZALLASI & P.M. BLUMBERG, Life Sci. 47 1399-1408 (1990b).
13. A. SZALLASI & P.M. BLUMBERG, Naunyn-Schmiedeberg's Arch. Pharmacol. 347 84-91 (1993).
14. A. SZALLASI, Gen Pharmac. 25 223-243 (1994).
15. A. SZALLASI, B. CONTE, C. GOSO, P.M. BLUMBERG, & S. MANZINI, Life Sci. 52 PL221-226 (1993).
16. C. GOSO, S. EVANGELISTA, M. TRAMONTANA, S MANZINI, P.M. BLUMBERG, & A. SZALLASI, Eur. J. Pharmacol. 249 185-190 (1993).
17. M. PARLANI, B. CONTE, C. GOSO, A. SZALLASI, & S. MANZINI, Br. J. Pharmacol. 110 989-994 (1993).
18. C. GOSO, S. MANZINI, P.M. BLUMBERG, & A. SZALLASI, Br. J. Pharmacol. 108 (Suppl.), 306P (1993).
19. L. LIU & S.A. SIMON, Proc. Natl. Acad. Sci. 91 738-741 (1994).
20. D. CAMERON-SMITH, E.Q. COLQUHOUN, J-M YE, M. HETTIARACHCHI, & M.G. CLARK, Int. J. Obesity 4 259-270 (1990).
21. T.P.D. ELDERSHAW, E.Q. COLQUHOUN, K.A. DORA, Z-C. PENG, & M.G. CLARK, Int. J. Obesity. 16 755-763 (1992).
22. T.P.D. ELDERSHAW, E.Q. COLQUHOUN, K.L. BENNETT, K.A. DORA, & M.G. CLARK, Life Sci. 55 389-397 (1994).
23. K.A. DORA, S.M. RICHARDS, S. RATTIGAN, E.Q. COLQUHOUN, & M.G. CLARK, Am. J. Physiol. 262 (Heart Circ. Physiol. 31), H698-H703 (1992).
24. B. GRUBB, & G.E. FOLK, J. Comp. Physiol. 110 217-226 (1976).
25. C. CÔTÉ, M.C. THIBAULT, & J. VALLIÈRES, Life Sci. 37 695-701 (1985).
26. M.G. CLARK, E.Q. COLQUHOUN, S. RATTIGAN, K.A. DORA, T.P.D. ELDERSHAW, J.L. HALL, & J-M. YE, Am. J. Physiol. 268 (Endocrinol. Metab. 31), E797-E812 (1995).
27. A. DRAY, C.A. FORBES, & G.M. BURGESS, Neurosci. Lett. 110 52-59 (1990).
28. Y-P. LOU, A. FRANCO-CERECEDA, & J.M. LUNDBERG, Acta Physiol. Scand. 146 119-127 (1992).
29. C.A. MAGGI, Capsaicin in the study of pain. J.N. Wood (Ed.), 161-190 Academic Press Ltd, London (1993).
30. AUSTRALIAN GOVERNMENT, Australian code of practice for the care and use of animals for scientific purposes. Australian Government Publishing Service, Canberra (1990).
31. E.Q. COLQUHOUN, M. HETTIARACHCHI, J-M. YE, E.A. RICHTER, A.J. HNIAT, S. RATTIGAN, & M.G. CLARK, Life Sci. 43 1747-1754 (1988).
32. C.A. MAGGI & A. MELI, Gen. Pharmac. 19 1-43 (1988)
33. G.E. ROVATI, & S. NICOSIA, Trends Pharmacol. Sci. 15 140-144 (1994).
34. E. SZABADI, J. Theor. Biol. 69 101-112 (1977).
35. T. KENAKIN, Pharmacologic analysis of drug-receptor interaction (2nd edition), Raven Press Ltd., New York (1993).
36. A.N. AKOPIAN, L. SIVILOTTI & J.N. WOOD, Nature 379 257-262 (1996).
37. B. LEIGHTON & E.A. FOOT Biochem. J. 307 707-712 (1995).